Skip to main content
Fig. 2 | Autoimmunity Highlights

Fig. 2

From: Potential clinical biomarkers in rheumatoid arthritis with an omic approach

Fig. 2

Flow diagram for screening and evidence selection. *The repeated article was excluded due to the biomarker having a different end up, and it may disturb the results of the study. *The articles that had little statistical power were not conclusive, and the statistical evaluation did not confirm the use of the biomarker. *The articles that had many limitations were excluded because the impossibility to find the optimal selection method, and factor omission which can affect the outcome. *The articles related to treating the subject with little force were also excluded due to lack of information between the treatment and the use of the biomarkers.

Back to article page